홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

4-oxo-4-[4-(2-oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidin-1-yl]-2-(5,6,7,8-tetrahydro-naphthalen-2-ylmethyl)-butanoic acid → methyl {1'-[4-oxo-4-[4-(2-oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidin-1-yl]-2-(5,6,7,8-tetrahydro-naphthalen-2-ylmethyl)-butyryl]-[4,4']bipiperidinyl-1-yl}-acetate

HRID 2311889
노트
인쇄 미리보기

반응식

HRID 2311889 반응식
[N:36]1([CH2:48][C:49](=[O:50])[O:51][CH3:52])[CH2:37][CH2:38][CH:39]([CH:42]2[CH2:43][CH2:44][NH:45][CH2:46][CH2:47]2)[CH2:40][CH2:41]1.[O:1]=[C:2]([CH2:3][CH:4]([C:5](=[O:6])[OH:7])[CH2:8][c:9]1[cH:10][c:11]2[c:16]([cH:17][cH:18]1)[CH2:15][CH2:14][CH2:13][CH2:12]2)[N:19]1[CH2:20][CH2:21][CH:22]([N:25]2[C:26](=[O:35])[NH:27][c:28]3[cH:29][cH:30][cH:31][cH:32][c:33]3[CH2:34]2)[CH2:23][CH2:24]1>>[O:1]=[C:2]([CH2:3][CH:4]([C:5](=[O:6])[N:45]1[CH2:44][CH2:43][CH:42]([CH:39]2[CH2:38][CH2:37][N:36]([CH2:48][C:49](=[O:50])[O:51][CH3:52])[CH2:41][CH2:40]2)[CH2:47][CH2:46]1)[CH2:8][c:9]1[cH:10][c:11]2[c:16]([cH:17][cH:18]1)[CH2:15][CH2:14][CH2:13][CH2:12]2)[N:19]1[CH2:20][CH2:21][CH:22]([N:25]2[C:26](=[O:35])[NH:27][c:28]3[cH:29][cH:30][cH:31][cH:32][c:33]3[CH2:34]2)[CH2:23][CH2:24]1
참가 물질출처 및 근거반응 노트

참가 물질

3

반응물 2

HCID 685791034-oxo-4-[4-(2-oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidin-1-yl]-2-(5,6,7,8-tetrahydro-naphthalen-2-ylmethyl)-butanoic acidHCID 70056900Methyl[4,4']bipiperidinyl-1-yl-acetate

생성물 1

HCID 59260973methyl {1'-[4-oxo-4-[4-(2-oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidin-1-yl]-2-(5,6,7,8-tetrahydro-naphthalen-2-ylmethyl)-butyryl]-[4,4']bipiperidinyl-1-yl}-acetate

출처 및 근거

ORD 기록
ord-ad405482abae45f3a592f49954f6dd03
출처 데이터셋
Training data from https://doi.org/10.1039/C8SC04228D (10/10)
DOI
10.1039/C8SC04228D

반응 노트

불러오는 중…

이 페이지에서참가 물질출처 및 근거반응 노트